bioAffinity (BIAF) Revenue & Revenue Breakdown
bioAffinity Revenue Highlights
Latest Revenue (Q)
$2.41B
Main Segment (Y)
Other Revenues
bioAffinity Revenue by Period
bioAffinity Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | -100.00% |
2022-12-31 | $4.80K | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
bioAffinity Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $2.41B | 108621.37% |
2023-12-31 | $2.21M | 641.53% |
2023-09-30 | $298.48K | 1412.23% |
2023-06-30 | $19.74K | 2043.11% |
2023-03-31 | $921.00 | -60.74% |
2022-12-31 | $2.35K | 104.00% |
2022-09-30 | $1.15K | -11.94% |
2022-06-30 | $1.31K | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | - |
bioAffinity Revenue Breakdown
bioAffinity Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 |
---|---|
Health Care, Other | $19.32K |
Other Revenues | $21.52K |
Quarterly Revenue by Product
Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 |
---|---|---|---|---|---|
Other Revenues | $23.92K | $427.00 | - | - | - |
Health Care, Other | $33.19K | $16.06K | $16.93K | $2.39K | - |
Laboratory Services | - | - | - | $7.42K | - |
Royalty Income | - | - | - | $5.41K | - |
Health Care, Patient Service | - | - | - | $248.65K | - |
Diagnostic Test | - | - | - | - | $7.00K |
bioAffinity Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
GTH | Genetron | $650.71M | $201.32M |
BIOC | Biocept | $25.86M | $589.00K |
PMD | Psychemedics | $22.10M | $5.36M |
PRPO | Precipio | $12.40M | $3.43M |
GENE | Genetic | $8.69M | $3.96M |
TTOO | T2 Biosystems | $7.19M | $1.95M |
HTGM | HTG Molecular Diagnostics | $6.37M | $1.03M |
INBS | Intelligent Bio Solutions | $1.26M | $823.80K |
SQL | SeqLL | $1.18K | - |
BIAF | bioAffinity | - | $2.41B |
BIAF Revenue FAQ
What is bioAffinity’s yearly revenue?
bioAffinity's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $4.8K, representing an increase of 100.00% compared to 2021. BIAF's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is bioAffinity’s quarterly revenue?
bioAffinity's quarterly revenue for Q1 2024 was $2.41B, a 108621.37% increase from the previous quarter (Q4 2023), and a 261280138.87% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.21M, a 641.53% increase from the previous quarter (Q3 2023), and a 94245.95% increase year-over-year (Q4 2022). BIAF's quarterly revenue for Q3 2023 was $298.48K, a 1412.23% increase from the previous quarter (Q2 2023), and a 25855.13% increase year-over-year (Q3 2022).
What is bioAffinity’s revenue growth rate?
bioAffinity's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.
What are bioAffinity’s revenue streams?
bioAffinity's revenue streams in c 23 are Health Care, Other, and Other Revenues. Health Care, Other generated $19.32K in revenue, accounting 47.32% of the company's total revenue Other Revenues generated $21.52K in revenue, accounting 52.68% of the company's total revenue
What is bioAffinity’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of bioAffinity was Other Revenues. This segment made a revenue of $21.52K, representing 52.68% of the company's total revenue.